Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 11 - 08    source : Www.biospace.com    save search

Adicet Bio to Participate in Stifel 2021 Virtual Healthcare Conference
Published: 2021-11-08 (Crawled : 22:00) - biospace.com/
ACET | News | $1.915 -8.81% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 1.52% H: 0.96% C: -0.21%

conference
Viatris Reports Strong Third Quarter Results, Raises 2021 Financial Guidance and Announces Virtual Investor Event on January 7, 2022
Published: 2021-11-08 (Crawled : 22:00) - biospace.com/
VTRS | News A | $11.485 1.1% 2.4M twitter stocktwits trandingview |
Health Technology
| | O: 5.03% H: 3.12% C: 1.8%

results
Trevena to Release Third Quarter 2021 Financial Results on November 15th, 2021Company to host conference call on Monday, November 15th, 2021 at 8:00 a.m. ET
Published: 2021-11-08 (Crawled : 22:00) - biospace.com/
TRVN | $0.388 30K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.98% C: -6.69%

financial results results conference
Gyroscope Therapeutics Announces Sanofi Investment of Up to $60 Million
Published: 2021-11-08 (Crawled : 22:00) - biospace.com/
SNYNF | News | $94.25 480 twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 950K twitter stocktwits trandingview |
Health Technology
| | O: -0.12% H: 0.0% C: 0.0%

therapeutics
Kamada to Announce Third Quarter Financial Results and Host Conference Call on November 22, 2021
Published: 2021-11-08 (Crawled : 21:00) - biospace.com/
KMDA | $5.21 2.16% 8.6K twitter stocktwits trandingview |
Health Technology
| | O: -1.69% H: 1.21% C: -0.69%

financial results results conference
Cerus Corporation to Participate in Stifel 2021 Virtual Healthcare Conference
Published: 2021-11-08 (Crawled : 21:00) - biospace.com/
CERS | $1.655 -1.49% 320K twitter stocktwits trandingview |
Health Technology
| | O: -2.15% H: 3.3% C: 0.52%

conference
Janux Therapeutics to Present Virtually at Upcoming Investor Conferences
Published: 2021-11-08 (Crawled : 21:00) - biospace.com/
JANX | $48.42 -2.73% 500K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 1.76% H: 6.19% C: -12.63%

conference therapeutics
Tempest Further Bolsters Patent Portfolio with Issuance of Multiple Patents for TPST-1495
Published: 2021-11-08 (Crawled : 21:00) - biospace.com/
TPST | $3.46 1.17% 590K twitter stocktwits trandingview |
Manufacturing
| | O: -2.05% H: 2.24% C: 1.67%

pest patent
RAPT Therapeutics to Participate in Upcoming Investor Conferences
Published: 2021-11-08 (Crawled : 21:00) - biospace.com/
RAPT | $7.895 -1.31% 180K twitter stocktwits trandingview |
Health Technology
| | O: 0.76% H: 0.18% C: -3.14%

conference therapeutics
New England Biolabs® releases next generation HiScribe™ in vitro transcription kit, incorporating TriLink® Biotechnologies' CleanCap® technology for mRNA synthesis
Published: 2021-11-08 (Crawled : 20:00) - biospace.com/
MRVI 4 | $7.635 -1.1% 770K twitter stocktwits trandingview |
Commercial Services
| | O: 3.46% H: 2.07% C: -1.33%

biotech technology iot in vitro
Rockwell Medical, Inc. to Report Third Quarter 2021 Financial and Operating Results on November 15, 2021
Published: 2021-11-08 (Crawled : 20:00) - biospace.com/
RMTI | $1.5 -1.96% 32K twitter stocktwits trandingview |
Health Technology
| | O: 0.88% H: 1.3% C: 0.22%

results
ENDRA Life Sciences to Report Third Quarter 2021 Financial Results on November 15, 2021
Published: 2021-11-08 (Crawled : 20:00) - biospace.com/
NDRA | $0.2546 0.08% 28K twitter stocktwits trandingview |
Health Technology
| | O: -1.38% H: 2.1% C: -1.4%

financial results results life science
NEXPLANON (etonogestrel extended-release subdermal implant) Now Covered by Quebec's Public Formulary
Published: 2021-11-08 (Crawled : 20:00) - biospace.com/
MRK | $127.345 0.37% 4.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.47% H: 3.07% C: 2.82%

implant
LivaNova Announces 2021 Virtual Investor Day
Published: 2021-11-08 (Crawled : 19:00) - biospace.com/
LIVN | $55.86 1.53% 350K twitter stocktwits trandingview |
Health Technology
| | O: -0.24% H: 0.21% C: -1.63%


Alligator Bioscience Announces Commencement of Investigator Initiated Phase I Clinical Trial at Erasmus University Rotterdam
Published: 2021-11-08 (Crawled : 18:00) - biospace.com/
APVO | $0.6827 -7.27% 530K twitter stocktwits trandingview |
Health Technology
| | O: -1.21% H: 1.22% C: -6.84%

trial initiated bioscience
Why Flu Vaccines are Recommended Despite Low Efficacy
Published: 2021-11-08 (Crawled : 18:00) - biospace.com/
SNYNF | News | $94.25 480 twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 950K twitter stocktwits trandingview |
Health Technology
| | O: -0.12% H: 0.0% C: 0.0%

vaccine
Conformis, Inc. Appoints James Paiva as its new Vice President of U.S. Marketing; Inducement Grant Reported
Published: 2021-11-08 (Crawled : 18:00) - biospace.com/
JNJ | News | $148.66 -0.6% 5.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.61% H: 0.0% C: 0.0%
CFMS | $2.26 0.44% 0 twitter stocktwits trandingview |
Health Technology
| | O: -0.85% H: 0.86% C: -1.72%

granted grant
Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 1/2 Clinical Trial Evaluating Gene Therapy Candidate OCU400
Published: 2021-11-08 (Crawled : 18:00) - biospace.com/
OCGN | News A | $1.165 -6.8% 6.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.4% H: 1.16% C: -6.33%

new drug fda application phase 1 gene therapy therapy drug trial submission
Helio Health and Fulgent Genetics Announce Late-Breaking Positive Performance Data of HelioLiver™ for Early Liver Cancer Detection
Published: 2021-11-08 (Crawled : 16:00) - biospace.com/
FLGT | $20.545 -0.46% 72K twitter stocktwits trandingview |
Health Services
| | O: 0.48% H: 4.47% C: 3.45%

genetic positive cancer liver
Crinetics Pharmaceuticals Presenting New Data from Open Label Extension Trial of Paltusotine in Acromegaly at the Society for Endocrinology BES Congress
Published: 2021-11-08 (Crawled : 16:00) - biospace.com/
CRNX G | $43.68 -1.22% 170K twitter stocktwits trandingview |
Health Technology
| | O: 2.15% H: 0.98% C: -2.42%

trial
Gainers vs Losers
58% 42%

Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M twitter stocktwits trandingview |
Consumer Services

CZOO | $11.04 121.24% 11M twitter stocktwits trandingview |

LICN | $0.9107 62.63% 14M twitter stocktwits trandingview |

BOF | $1.87 59.83% 100M twitter stocktwits trandingview |

AMST | $3.18 59.0% 67M twitter stocktwits trandingview |
Technology Services

MTC | $3.31 47.77% 7.7M twitter stocktwits trandingview |
Technology Services

MULN | News | $3.915 43.41% 12M twitter stocktwits trandingview |
Information

WIMI | $1.04 43.37% 17M twitter stocktwits trandingview |
Technology Services

SKIL 4 | $8.045 40.89% 230K twitter stocktwits trandingview |
Information

RILY | $30.01 38.17% 11M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.